Lori-AnnFisher University of the West Indies, MonaJamaica

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? Fatiu AbiolaArogundade Chairperson fatiu3@yahoo.comObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria Nigeria FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comUniversidade Federal do Rio Grande do SulBrazil OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduDuke University School of MedicineUnited States Ethical Aspects of Race-based Genetic Testing AnaIltis Speaker iltisas@wfu.eduWake Forest UniversityUnited States Contribution of ApoL1 Risk Genotype to HIVAN SaraladeviNaicker Speaker University of the Witwatersrand South Africa Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa DwomoaAdu Speaker dwoms@blueyonder.co.ukUniversity of Ghana Medical SchoolGhana Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials OgoEgbuna Speaker ogo_egbuna@vrtx.comVertex Pharmaceuticals IncUnited States Q and A Hall C2
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria Hall A
4:30 p.m. 5:30 p.m.	Policy and Advocacy Approaches Lori-AnnFisher Chairperson lori2k15@gmail.comUniversity of the West Indies, MonaJamaica MarcelloTonelli Chairperson cello@ucalgary.caSenior Associate Dean (Clinical Research), CummingCanada Universal Health Coverage for Kidney Diseases: Feasibility, Barriers, and Opportunities for Improving Global Kidney Health VivekanandJha Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia The Role of Kidney Health Advocacy Organizations in Reducing the Global Burden of Kidney Diseases ValerieLuyckx Speaker valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Case for National Prevention Programs to Manage CKD IkechiOkpechi Speaker University of AlbertaCanada Q and A Hall A